Fresenius Kabi

fresenius-kabi.com · Bad Homburg vor der Höhe, Germany

Fresenius Kabi is a global healthcare company that develops, manufactures, and distributes injectable drugs, infusion therapies, clinical nutrition products, and related medical devices for hospitals, clinics, and home care providers. The company focuses on therapies for critically and chronically ill patients, generating revenue through the sale of pharmaceuticals, nutrition solutions, and infusion and transfusion technologies worldwide.

Revenue
$1B+
Employees
5,001+
Founded
1999
Headquarters
Bad Homburg vor der Höhe, Germany

Fresenius Kabi customers on Arbolus

Total customers 11 11 current · 0 former
Reviews growth 7 new reviews since May 2026

Customers who reviewed Fresenius Kabi

Seniority of Fresenius Kabi customers

Most people who reviewed Fresenius Kabi hold C-Suite roles (64%), followed by Director (36%).

  • C-Suite 64%
  • Director 36%

Customers sample

Revenue Leader Director NPS 10 Undecided
Strategy Partner C-Suite NPS 9 Undecided
Other Generalist Director NPS 10

Employer names and spend open once the report publishes.

What 11 Arbolus experts think of Fresenius Kabi

Overall sentiment: Positive

NPS scores range from 7 to 10, indicating generally positive sentiment among both Influencer and User categories. Renewal intent shows a mixed pattern, with 50% expressing uncertainty and 37.5% affirming renewal. Stickiness is high, with 87.5% in 'More Than 1 Year' or 'Less Than 1 Year' post-implementation, but a notable portion are still in evaluation stages such as 'Pilot'. Key themes include above-average satisfaction, but also cautious long-term commitment and desire for assurance in ongoing value.

Tell us when the Fresenius Kabi report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Sentiment

36 Net Promoter Score, from 11 scored reviews
  • Promoters 5
  • Passives 5
  • Detractors 1

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 33%
  • Will renew 2
  • Undecided 4
  • Not renewing 0

Plan to renew, by seniority

  • C-Suite 0% 3 answers
  • Director 67% 3 answers
  • 7.5/10 Average score from customers who will renew
  • 8.3/10 Average score from undecided customers

Top alternatives

Most weighed by Fresenius Kabi customers

For people who use Fresenius Kabi

Do you use Fresenius Kabi at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 11 customers of Fresenius Kabi have already contributed

Takes a few minutes. Your identity stays anonymous.